Skip to Main Content

Paper Details

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
Blood Adv
2
2023
Author NameAffiliation
Ravindra MajetiCancer Institute, Stanford University School of Medicine
Christopher S Houriganand Blood Institute, National Institutes of Health
Stephanie HaleneYale University School of Medicine and Yale Cancer Center
Uma BorateJames Cancer Center, Ohio State University
Rafael BejarMoores Cancer Center, university of california san diego
David P SteensmaNovartis Institutes of BioMedical Research.
  • 1 - 6

Datasets

Release 1.2